SIONNA THERAPEUTICS, INC. Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale
SIONNA THERAPEUTICS, INC. (SION) reported Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale of $104.65 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities · last filed 2026-08-06
- SIONNA THERAPEUTICS, INC. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for the quarter ending 2026-06-30 was $54.50M, a 64.30% increase year-over-year.
- SIONNA THERAPEUTICS, INC. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for the quarter ending 2026-03-31 was $50.15M, a 64.49% increase year-over-year.
- SIONNA THERAPEUTICS, INC. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for the quarter ending 2025-12-31 was $65.67M, a 192.45% increase year-over-year.
- SIONNA THERAPEUTICS, INC. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for the quarter ending 2025-09-30 was $77.33M, a 130.82% increase year-over-year.
- SIONNA THERAPEUTICS, INC. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for fiscal 2025 was $206.65M, a 269.32% increase from fiscal 2024.
- SIONNA THERAPEUTICS, INC. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for fiscal 2024 was $55.95M.
| Period end | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 3 month | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 6 month | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 9 month | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 12 month |
|---|---|---|---|---|
| 2026-06-30 | $54.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $104.65M 10-Q · filed 2026-08-06 | $170.32M derived: sum of 3 quarters · filed 2026-08-06 | $247.64M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $50.15M 10-Q · filed 2026-05-12 | $115.82M derived: sum of 2 quarters · filed 2026-05-12 | $193.14M derived: sum of 3 quarters · filed 2026-05-12 | $226.31M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $65.67M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $143.00M derived: sum of 2 quarters · filed 2026-03-02 | $176.17M derived: sum of 3 quarters · filed 2026-08-06 | $206.65M 10-K · filed 2026-03-02 |
| 2025-09-30 | $77.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $110.50M derived: sum of 2 quarters · filed 2026-08-06 | $140.98M 10-Q · filed 2025-11-05 | $163.44M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $33.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $63.66M 10-Q · filed 2026-08-06 | $86.11M derived: sum of 3 quarters · filed 2026-08-06 | $119.61M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $30.49M 10-Q · filed 2026-05-12 | $52.94M derived: sum of 2 quarters · filed 2026-05-12 | $86.44M derived: sum of 3 quarters · filed 2026-05-12 | $86.44M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $22.45M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $55.95M derived: sum of 2 quarters · filed 2026-03-02 | $55.95M derived: sum of 3 quarters · filed 2026-03-02 | $55.95M 10-K · filed 2026-03-02 |
| 2024-09-30 | $33.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $33.50M derived: sum of 2 quarters · filed 2025-11-05 | $33.50M 10-Q · filed 2025-11-05 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $0.00 10-Q · filed 2025-08-11 | ||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |